SCHEMBL21135998

SCHEMBL21135998

CCC(F)(OC(=O)C12CC3CC(CC(C3)C1)C2)S(=O)(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.42
CYP19A1 P11511 3/20 0.42
ALDH1A1 P00352 4/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PRKCA P17252 1/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
ATM Q13315 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
XBP1 P17861 1/20 0.36
PKM P14618 1/20 0.35
HSD11B1 P28845 1/20 0.35
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136601 0.90 CYP17A1 (0.39) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL21136610 0.87 CYP17A1 (0.39) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL11991323 0.81 CYP17A1 (0.42) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL21136959 0.79 CYP17A1 (0.38) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL17590217 0.78 CYP17A1 (0.43) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL17410591 0.78 CYP17A1 (0.40) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL15858407 0.78 ALDH1A1 (0.42) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL13705971 0.76 CYP17A1 (0.50) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL14616379 0.75 CYP17A1 (0.42) CYP17A1CYP19A1ALDH1A1KMT2AMEN1
SCHEMBL6754655 0.75 CYP17A1 (0.42) CYP17A1CYP19A1ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190196326-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190196326-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE RER1, ACTR5, RAD51 CYP17A1 2517/4885CYP19A1 1662/4885ALDH1A1 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.